Form 8-K - Current report:
SEC Accession No. 0001213900-22-005921
Filing Date
2022-02-08
Accepted
2022-02-08 16:30:38
Documents
13
Period of Report
2022-02-08
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea155107-8k_citiuspharm.htm   iXBRL 8-K 45073
  Complete submission text file 0001213900-22-005921.txt   263986

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ctxr-20220208.xsd EX-101.SCH 3737
3 XBRL DEFINITION FILE ctxr-20220208_def.xml EX-101.DEF 26822
4 XBRL LABEL FILE ctxr-20220208_lab.xml EX-101.LAB 36824
5 XBRL PRESENTATION FILE ctxr-20220208_pre.xml EX-101.PRE 25444
7 EXTRACTED XBRL INSTANCE DOCUMENT ea155107-8k_citiuspharm_htm.xml XML 7067
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 22602024
SIC: 2834 Pharmaceutical Preparations